Rapid Intrahepatic Tumor Seeding after Percutaneous Ethanol Injection Therapy for Hepatocellular Carcinoma
スポンサーリンク
概要
- 論文の詳細を見る
A 73-year-old man with hepatocellular carcinoma (HCC) had been treated repeatedly with transcatheter arterial embolization (TAE) and percutaneous ethanol injection therapy (PEIT) since 2000. HCC recurrence near the intrahepatic left portal vein was treated by PEIT in 2004. The patient complained of fatigue and upper abdominal pain 28 days later. Abdominocentesis and abdominal computed tomography demonstrated rupture of the recurrent HCC and multiple intrahepatic recurrences. We successfully performed emergency TAE, but the patient died of liver failure. Rapid seeding of multiple intrahepatic tumors after PEIT is a rare event, but such a possibility must be kept in mind.
著者
-
Tanaka Hiroto
The Third Department of Internal Medicine, Wakayama Medical University
-
Ueda Hiroki
The Third Department of Internal Medicine, Wakayama Medical University
-
Kida Yohei
The Third Department of Internal Medicine, Wakayama Medical University
-
Fukuchi Hiroko
The Third Department of Internal Medicine, Wakayama Medical University
-
Ichinose Masakazu
The Third Department of Internal Medicine, Wakayama Medical University
-
Ichinose Masakazu
The Third Department Of Internal Medicine Wakayama Medical University
関連論文
- Rapid Intrahepatic Tumor Seeding after Percutaneous Ethanol Injection Therapy for Hepatocellular Carcinoma
- Serum Antibody Against Granulocyte/Macrophage Colony-Stimulating Factor and KL-6 in Idiopathic Pulmonary Alveolar Proteinosis
- Long-Term Use of Corticosteroid Eye Drops Delays the Spontaneous Remission of Pulmonary Sarcoidosis
- High COPD Prevalence in Patients with Liver Disease
- Peak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics
- Efficacy and Safety of Formoterol in Japanese Patients with COPD
- Validation of the Triaxial Accelerometer for the Evaluation of Physical Activity in Japanese Patients with COPD
- 2. Advances in Pharmacotherapy for COPD